A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647
Clinical trial NCT05105048 · COMPLETED
Trial details
- NCT number
- NCT05105048
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-08
- Primary completion
- 2023-08-10
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.